retatrutide vs vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide vs. semaglutide: A head-to-head

Nausea is the most common, affecting up to 60% of people on the highest 12 mg dose in the Phase 2 trial and around 43% in TRIUMPH-4

However, prostate cancer reports remain inconclusive and require further research [69]

GLP-1 also slows down how fast food moves through your stomach (gastric emptying), making you feel full longer, and helps control appetite by lowering blood sugar levels and promoting weight loss

Common contributors to gastroparesis include systemic and metabolic disorders, with prevalent factors being diabetes (25%), medications (22%), postsurgical reasons (7%), and additional factors such as Parkinsons disease, connective tissue disorders, and specific infections such as enteroviruses [2]

Interacciones con otros medicamentos: Debido a que los GLP-1 retrasan el vaciamiento gstrico, pueden afectar la absorcin de medicamentos orales